"University health centers such as our own must either help create change or be over whelmed by economic forces beyond our control," adds Dr. Robert W. Cantrell, vice president and provost for Health Sciences.
Accordingly, the Health Sciences Center took decisive steps during the past year to adapt to new marketplace realities, to improve the quality of patient care, and to place health care at U.Va. on a sure financial footing. These efforts produced improvements in price, quality, and service in 1994-95. The U.Va. Medical Center is now one of the five least costly hospitals in the University Hospital Consortium, a national group of academic medical centers. Along with this reduction in costs, the average length of patient stay has decreased from 6.6 days to 6.4 days, and care is being provided in a more efficient and effective manner.
In 1994-95, the Health Sciences Center made progress in a number of areas:
Dr. Cantrell, newly appointed vice president and provost for health sciences.
In October, the University announced the appointment of Dr. Don E.
Detmer as senior vice president and University Professor, effective January
1, 1996. Dr. Detmer will represent the University on health policy issues at
the national level. Much of that work will be accomplished through the
Virginia Health Policy Center, which he was instrumental in founding and
has co-directed since 1991.
Dr. Cantrell, who has served as interim vice president and provost since January 1995, was named to that permanent position in November. Dr. Cantrell has been on the faculty since 1976. He is a former president of the American Academy of Otolaryngology-Head and Neck Surgery and has held high offices in many other professional organizations. He is the author or coauthor of more than two hundred professional publications. He has served as a consult ant to the U.S. Surgeon General, the National Institutes of Health, and other state and federal agencies. Dr. Cantrell was awarded one of five Presidential Citations from the American Academy of Otolaryngology-Head and Neck Surgery, presented at the 99th annual meeting of the association this fall.
In the Laboratory for Clinical Learning, undergraduate nursing students learn to place and care for intravenous lines.
One reason for our strong showing in these rankings is the University's policy of integrating basic research and clinical practice. This characteristic was highlighted when the Cancer Center moved to its new home in the Medical Center. By bringing together researchers and clinicians, the center's leaders hope to speed the introduction of new cancer-fighting drugs and therapies.
In fact, research currently being conducted in the School of Medicine is making possible promising new treatments for cancer and other diseases. Long-term research by Dr. Joseph Larner offers a way to correct the cellular malfunctioning underlying Type II diabetes, the fourth leading cause of death by disease in the United States, by isolating two key compounds that are reduced or absent in people with Type II diabetes.
Dr. Barry Marshall recently received the American Gastroenterological Association's Distinguished Achievement Award for his work linking bacterial infection to dyspepsia, ulcers, and gastric cancer. He has developed a fourteen-day antibiotic and bismuth therapy to eradicate the bacterium and devised a breath test that confirms its presence in patients within twenty minutes.
Ronald Taylor and his colleagues are doing research with even broader implications. They have invented a modified antibody that may help red blood cells battle disease. Taylor's work could be used to treat a wide variety of diseases, including such autoimmune diseases as arthritis, systemic lupus erythematosus, and myasthenia gravis.
Many of the next generation of vaccines and drug treatments will depend on scientists' ability to strengthen the body's own defenses against infection. The key is to identify the telltale proteins produced by the body's invaders and then develop drugs that target them. Donald F. Hunt, professor of chemistry and pathology, has assembled a unique system for determining protein sequencestandem mass spectrometrythat is up to a thousand times more sensitive than previous methods. Scientists are using this technique to search for other antigens that alert the immune system to viral infections, bacterial infections, and various cancers. Now, with a $750,000 grant from the W. M. Keck Foundation, the University has been able to create a Center for Biomedical Mass Spectrometry to make this crucial tool available to researchers nationally.
Go on to Readying the Grounds for the 21st Century
Return to the President's Report Table of Contents
Office of University Publications Home Page
University of Virginia Home Page